Advertisement

Neurological Sciences

, Volume 34, Issue 9, pp 1689–1690 | Cite as

A pediatric case of Miller Fisher syndrome with central involvement

  • D. Ajena
  • S. Ferrari
  • S. Romito
  • F. Zaglia
  • P. Biban
  • G. Squintani
Letter to the Editor

Dear Editor-in-Chief,

Miller Fisher syndrome (MFS) is a rare condition characterized by external ophthalmoplegia, ataxia, and areflexia, and is considered a clinical variant of Guillain-Barré syndrome (GBS). Reports on MFS with Bickerstaff brainstem encephalitis (BBE) overlapping are also reported and a clear distinction between the two disorders is still debated [1]. Nevertheless, both clinical pictures are characterized in up to 90 % of cases by high titre of serum anti GQ1b antibodies, which have a clear pathogenetic role.

We describe a rare case of pediatric MFS with clinical central involvement, and a good recovery after the second cycle of intravenous immunoglobulin (IVIg), suggesting a therapeutic efficacy of immunomodulatory treatment.

A six-year-old child was referred to our Hospital for acute onset of diplopia, left palpebral ptosis and sixth left nerve palsy associated to gait ataxia. The day after, the patient worsened with drowsiness, ophthalmoplegia, dysphagia and...

Keywords

Muscle Spindle Ophthalmoplegia Somatosensory Evoke Potential Miller Fisher Syndrome Central Involvement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Yuki N (2009) Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome). J Neuroimmunol 215:1–9PubMedCrossRefGoogle Scholar
  2. 2.
    Fargas i Busquets A, Roig Quilis M, Gratacòs Vinyola M, Macaya Ruiz A, Del Toro Riera M, Fitó Costa A (1998) Ophthalmoplegia-ataxia-areflexia in pediatrics. Three new patients and review of the literature. An Esp Pediatr 48:483–488Google Scholar
  3. 3.
    Odaka M, Yuki N, Hirata K (2001) Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 70:50–55PubMedCrossRefGoogle Scholar
  4. 4.
    Lin JJ, Hsia SH, Wang HS, Lyu RK, Chou ML, Hung PC, Hsieh MY, Lin KL (2012) Clinical variants of Guillain-Barré syndrome in children. Pediatr Neurol 47:91–96PubMedCrossRefGoogle Scholar
  5. 5.
    Liu JX, Willison HJ, Pedrosa-Domellöf F (2009) Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci 50:3226–3232PubMedCrossRefGoogle Scholar
  6. 6.
    Mori M, Kuwabara S, Fukutake T, Hattori T (2007) Intravenous immunoglobulin therapy for Miller Fisher syndrome. Neurology 68:1144–1446PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • D. Ajena
    • 1
  • S. Ferrari
    • 1
  • S. Romito
    • 2
  • F. Zaglia
    • 3
  • P. Biban
    • 3
  • G. Squintani
    • 2
  1. 1.Section of Clinical NeurologyUniversity of VeronaVeronaItaly
  2. 2.Neurology UnitAzienda Ospedaliera Universitaria IntegrataVeronaItaly
  3. 3.Pediatric UnitAzienda Ospedaliera Universitaria IntegrataVeronaItaly

Personalised recommendations